In our study, we found that CXCR2 and its downstream signaling, both Akt and Erk1/2, were activated in both microglia and macrophages after the treatment of oxPDCD and oxPdcd GBM medium, resulting in a significant increase of cell migration. The gene discussed is AKT1; the disease is glioblastoma.